Tissue engineering of heart valves: in vitro experiences
- PMID: 10921698
- DOI: 10.1016/s0003-4975(00)01255-8
Tissue engineering of heart valves: in vitro experiences
Abstract
Background: Tissue engineering is a new approach, whereby techniques are being developed to transplant autologous cells onto biodegradable scaffolds to ultimately form new functional tissue in vitro and in vivo. Our laboratory has focused on the tissue engineering of heart valves, and we have fabricated a trileaflet heart valve scaffold from a biodegradable polymer, a polyhydroxyalkanoate. In this experiment we evaluated the suitability of this scaffold material as well as in vitro conditioning to create viable tissue for tissue engineering of a trileaflet heart valve.
Methods: We constructed a biodegradable and biocompatible trileaflet heart valve scaffold from a porous polyhydroxyalkanoate (Meatabolix Inc, Cambridge, MA). The scaffold consisted of a cylindrical stent (1 x 15 x 20 mm inner diameter) and leaflets (0.3 mm thick), which were attached to the stent by thermal processing techniques. The porous heart valve scaffold (pore size 100 to 240 microm) was seeded with vascular cells grown and expanded from an ovine carotid artery and placed into a pulsatile flow bioreactor for 1, 4, and 8 days. Analysis of the engineered tissue included biochemical examination, enviromental scanning electron microscopy, and histology.
Results: It was possible to create a trileaflet heart valve scaffold from polyhydroxyalkanoate, which opened and closed synchronously in a pulsatile flow bioreactor. The cells grew into the pores and formed a confluent layer after incubation and pulsatile flow exposure. The cells were mostly viable and formed connective tissue between the inside and the outside of the porous heart valve scaffold. Additionally, we demonstrated cell proliferation (DNA assay) and the capacity to generate collagen as measured by hydroxyproline assay and movat-stained glycosaminoglycans under in vitro pulsatile flow conditions.
Conclusions: Polyhydroxyalkanoates can be used to fabricate a porous, biodegradable heart valve scaffold. The cells appear to be viable and extracellular matrix formation was induced after pulsatile flow exposure.
Similar articles
-
Fabrication of a trileaflet heart valve scaffold from a polyhydroxyalkanoate biopolyester for use in tissue engineering.Tissue Eng. 2000 Apr;6(2):183-8. doi: 10.1089/107632700320793. Tissue Eng. 2000. PMID: 10941212
-
Early in vivo experience with tissue-engineered trileaflet heart valves.Circulation. 2000 Nov 7;102(19 Suppl 3):III22-9. doi: 10.1161/01.cir.102.suppl_3.iii-22. Circulation. 2000. PMID: 11082357
-
Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.Ann Thorac Surg. 2006 Jun;81(6):2207-16. doi: 10.1016/j.athoracsur.2005.12.073. Ann Thorac Surg. 2006. PMID: 16731156
-
Scaffold design and fabrication technologies for engineering tissues--state of the art and future perspectives.J Biomater Sci Polym Ed. 2001;12(1):107-24. doi: 10.1163/156856201744489. J Biomater Sci Polym Ed. 2001. PMID: 11334185 Review.
-
Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.Placenta. 2011 Oct;32 Suppl 4:S316-9. doi: 10.1016/j.placenta.2011.04.001. Epub 2011 May 14. Placenta. 2011. PMID: 21575988 Review.
Cited by
-
Getting to the heart of tissue engineering.J Cardiovasc Transl Res. 2008 Mar;1(1):71-84. doi: 10.1007/s12265-007-9005-x. Epub 2008 Jan 29. J Cardiovasc Transl Res. 2008. PMID: 20559960 Review.
-
Heart valve and arterial tissue engineering.Cell Prolif. 2003 Oct;36(5):241-54. doi: 10.1046/j.1365-2184.2003.00281.x. Cell Prolif. 2003. PMID: 14521518 Free PMC article. Review.
-
Optimal elastomeric scaffold leaflet shape for pulmonary heart valve leaflet replacement.J Biomech. 2013 Feb 22;46(4):662-9. doi: 10.1016/j.jbiomech.2012.11.046. Epub 2013 Jan 5. J Biomech. 2013. PMID: 23294966 Free PMC article.
-
Progressive Reinvention or Destination Lost? Half a Century of Cardiovascular Tissue Engineering.Front Cardiovasc Med. 2020 Sep 9;7:159. doi: 10.3389/fcvm.2020.00159. eCollection 2020. Front Cardiovasc Med. 2020. PMID: 33033720 Free PMC article. Review.
-
In vivo application of poly-3-hydroxyoctanoate as peripheral nerve graft.J Zhejiang Univ Sci B. 2013 Nov;14(11):993-1003. doi: 10.1631/jzus.B1300016. J Zhejiang Univ Sci B. 2013. PMID: 24190445 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources